Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROVIDE: Boceprevir for HCV Genotype 1 Nonresponders
NCT00910624Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2009
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of boceprevir in hepatitis C (HCV), sponsored by Merck & Co.. Started Jun 2009; status: completed.
02
Drugs
boceprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00910624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00910624.